Biogen Pharmachem Industries Limited (BOM:531752)
India flag India · Delayed Price · Currency is INR
0.6500
-0.0300 (-4.41%)
At close: Jan 20, 2026

BOM:531752 Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
Net Income
17.16-2.9319.314.56-0.09-16.03
Upgrade
Other Operating Activities
-0----0-
Upgrade
Change in Accounts Receivable
----25.454.85
Upgrade
Change in Accounts Payable
---18.4-0.610.61
Upgrade
Change in Other Net Operating Assets
-3.79-7.890.14-5.91-10.730.07
Upgrade
Operating Cash Flow
13.37-10.8219.4517.0413.9839.5
Upgrade
Operating Cash Flow Growth
--14.09%21.89%-64.60%-
Upgrade
Investment in Securities
-186.37-184.0134.1-1925.39-30.44
Upgrade
Investing Cash Flow
-432.95-326.19-20.56-16.59-13.23-36.4
Upgrade
Short-Term Debt Repaid
------3.06
Upgrade
Total Debt Repaid
------3.06
Upgrade
Net Debt Issued (Repaid)
------3.06
Upgrade
Issuance of Common Stock
420357----
Upgrade
Financing Cash Flow
420357----3.06
Upgrade
Miscellaneous Cash Flow Adjustments
---0---
Upgrade
Net Cash Flow
0.4219.99-1.120.460.760.04
Upgrade
Levered Free Cash Flow
7.2-9.582.2511.2716.5854.95
Upgrade
Unlevered Free Cash Flow
7.2-9.582.2511.2716.5854.95
Upgrade
Change in Working Capital
-3.79-7.890.1412.4914.0755.53
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.